These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7698193)

  • 1. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
    Milanés MV; Vargas ML; Martín MI
    Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kappa opioid receptor antagonism produces supersensitivity to U-50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level.
    Alcaraz C; Milanés MV; Vargas ML
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1385-9. PubMed ID: 8396634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
    Alcaraz C; Vargas ML; Fuente T; Milanés MV
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic mechanisms involved in calcitonin potentiation of kappa-opioid receptor-mediated effects on adrenal secretion.
    Ormazábal MJ; Milanés MV; Martín MI
    Eur J Pharmacol; 1997 Dec; 340(1):81-7. PubMed ID: 9527510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
    Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
    Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of U50,488H fails to produce hypothalamo-pituitary-adrenal axis tolerance in neonatal rats.
    Ignar DM; Windh RT; Kuhn CM
    Neuropharmacology; 1992 Feb; 31(2):143-8. PubMed ID: 1553027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
    Iyengar S; Kim HS; Wood PL
    J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice.
    Narita M; Takahashi Y; Takamori K; Funada M; Suzuki T; Misawa M; Nagase H
    Jpn J Pharmacol; 1993 May; 62(1):15-24. PubMed ID: 8393497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis in rats.
    Adamson WT; Windh RT; Blackford S; Kuhn CM
    Endocrinology; 1991 Aug; 129(2):959-64. PubMed ID: 1649751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat.
    Ignar DM; Kuhn CM
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1287-95. PubMed ID: 2175800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats.
    Diop L; Rivière PJ; Pascaud X; Dassaud M; Junien JL
    Eur J Pharmacol; 1994 May; 257(1-2):181-7. PubMed ID: 8082700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
    Laorden ML; Milanés MV
    Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
    Iyengar S; Kim HS; Wood PL
    Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral kappa-opioid receptors mediate the antinociceptive effect of fedotozine (correction of fetodozine) on the duodenal pain reflex inrat.
    Diop L; Rivière PJ; Pascaud X; Junien JL
    Eur J Pharmacol; 1994 Dec; 271(1):65-71. PubMed ID: 7698213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor.
    Taylor CC; Wu D; Soong Y; Yee JS; Szeto HH
    J Pharmacol Exp Ther; 1996 May; 277(2):877-84. PubMed ID: 8627570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice.
    Kuzmin AV; Semenova S; Gerrits MA; Zvartau EE; Van Ree JM
    Eur J Pharmacol; 1997 Mar; 321(3):265-71. PubMed ID: 9085036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.